Syra Health annual revenue
2022
2023
2024
2025
Syra Health Revenue Growth & History (SYRA)
Syra Health reported $7.2M in revenue for fiscal 2025, a decrease of 9.47% from the previous fiscal year.
View full Syra Health company overviewSyra Health annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.2M | −$756,109 | −9.47% |
| 2024 | 2024-12-31 | $8.0M | $2.5M | +44.73% |
| 2023 | 2023-12-31 | $5.5M | −$102,562 | −1.83% |
| 2022 | 2022-12-31 | $5.6M | — | — |
Syra Health quarterly revenue
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.4M | $448,224 | +23.03% |
| Q1 2026 | 2026-03-31 | $2.3M | $415,746 | +22.38% |
| Q4 2025 | 2025-12-31 | $1.7M | −$272,696 | −13.59% |
| Q3 2025 | 2025-09-30 | $1.7M | −$565,365 | −25.09% |
| Q2 2025 | 2025-06-30 | $1.9M | −$23,482 | −1.19% |
| Q1 2025 | 2025-03-31 | $1.9M | $105,434 | +6.02% |
| Q4 2024 | 2024-12-31 | $2.0M | $240,524 | +13.62% |
| Q3 2024 | 2024-09-30 | $2.3M | $671,992 | +42.49% |
| Q2 2024 | 2024-06-30 | $2.0M | $990,433 | +101.14% |
| Q1 2024 | 2024-03-31 | $1.8M | $563,989 | +47.46% |
| Q4 2023 | 2023-12-31 | $1.8M | — | — |
| Q3 2023 | 2023-09-30 | $1.6M | $67,365 | +4.45% |
| Q2 2023 | 2023-06-30 | $979,248 | — | — |
| Q1 2023 | 2023-03-31 | $1.2M | — | — |
| Q3 2022 | 2022-09-30 | $1.5M | — | — |
Syra Health revenue growth trends
Syra Health's latest reported quarter, Q2 2026, generated $2.4M in revenue, an increase of 23.03% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Syra Health source filings ↗